# A Phase II Study to Evaluate the Efficacy and Safety of D-2570 in Subjects With Active Psoriatic Arthritis

> **NCT07315061** · PHASE2 · RECRUITING · sponsor: **InventisBio Co., Ltd** · enrollment: 222 (estimated)

## Conditions studied

- PsA (Psoriatic Arthritis)

## Interventions

- **DRUG:** D-2570
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT07315061
- **Lead sponsor:** InventisBio Co., Ltd
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2026-01-16
- **Primary completion:** 2027-08-15
- **Final completion:** 2028-08-06
- **Target enrollment:** 222 (ESTIMATED)
- **Last updated:** 2026-04-22


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07315061

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07315061, "A Phase II Study to Evaluate the Efficacy and Safety of D-2570 in Subjects With Active Psoriatic Arthritis". Retrieved via AI Analytics 2026-06-05 from https://api.ai-analytics.org/clinical/NCT07315061. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*